![Michelle Avery](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Michelle Avery
Sociétés | Poste | Début | Fin |
---|---|---|---|
PANDION THERAPEUTICS, INC. | Investor Relations Contact | 01/09/2020 | - |
Historique de carrière de Michelle Avery
Anciens postes connus de Michelle Avery
Sociétés | Poste | Début | Fin |
---|---|---|---|
Summit Therapeutics Ltd.
![]() Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Investor Relations Contact | - | - |
Public Communications Contact | - | - |
Statistiques
Internationale
Royaume-Uni | 2 |
Etats-Unis | 2 |
Opérationnelle
Investor Relations Contact | 2 |
Public Communications Contact | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Summit Therapeutics Ltd.
![]() Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Pandion Therapeutics, Inc.
![]() Pandion Therapeutics, Inc. BiotechnologyHealth Technology Pandion Therapeutics, Inc. is a clinical stage biopharmaceutical company. It develops Therapeutic Autoimmune reguLatOry proteiN (TALON) drug design and discovery platform, which employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded by Dr. Joanne Viney on September 19, 2016 and is headquartered in Watertown, MA. | Health Technology |
- Bourse
- Insiders
- Michelle Avery
- Expérience